• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    12 Consumer Staples Stocks Moving In Tuesday's After-Market Session

    4/9/24 4:31:12 PM ET
    $BRSH
    $COOT
    $ELAB
    $FARM
    Medical/Dental Instruments
    Health Care
    Packaged Foods
    Consumer Staples
    Get the next $BRSH alert in real time by email

    Gainers

    • Farmer Bros (NASDAQ:FARM) stock increased by 4.8% to $3.48 during Tuesday's after-market session. The company's market cap stands at $73.3 million.
    • Pricesmart (NASDAQ:PSMT) stock moved upwards by 4.69% to $86.99. The market value of their outstanding shares is at $2.6 billion. As per the press release, Q2 earnings came out today.
    • Hempacco (NASDAQ:HPCO) shares rose 4.34% to $1.44. The market value of their outstanding shares is at $5.2 million.
    • Elevai Labs (NASDAQ:ELAB) stock rose 3.63% to $0.62. The company's market cap stands at $10.7 million.
    • Mangoceuticals (NASDAQ:MGRX) shares moved upwards by 2.61% to $0.28. The company's market cap stands at $6.3 million.
    • Bruush Oral Care (NASDAQ:BRSH) shares increased by 2.51% to $0.05. The market value of their outstanding shares is at $5.3 million.

    Losers

    • WD-40 (NASDAQ:WDFC) shares decreased by 3.5% to $246.07 during Tuesday's after-market session. The company's market cap stands at $3.3 billion. The company's, Q2 earnings came out today.
    • Smart for Life (NASDAQ:SMFL) shares decreased by 3.0% to $0.65.
    • Honest Co (NASDAQ:HNST) shares declined by 2.96% to $3.61. The market value of their outstanding shares is at $346.1 million.
    • Australian Oilseeds Hldgs (NASDAQ:COOT) stock fell 2.48% to $1.4. The market value of their outstanding shares is at $32.6 million.
    • Reborn Coffee (NASDAQ:REBN) stock declined by 1.71% to $1.15. The company's market cap stands at $3.1 million.
    • Veru (NASDAQ:VERU) stock fell 1.69% to $1.15. The company's market cap stands at $168.3 million. See Also: www.benzinga.com/money/best-consumer-defensive-stocks/

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $BRSH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BRSH
    $COOT
    $ELAB
    $FARM

    CompanyDatePrice TargetRatingAnalyst
    The Honest Company Inc.
    $HNST
    1/16/2026Overweight → Underweight
    Analyst
    Veru Inc.
    $VERU
    12/18/2025$25.00Buy
    Canaccord Genuity
    The Honest Company Inc.
    $HNST
    11/6/2025$3.00Buy → Hold
    Lake Street
    The Honest Company Inc.
    $HNST
    11/6/2025$6.00 → $3.00Market Perform
    Telsey Advisory Group
    Farmer Brothers Company
    $FARM
    9/12/2025$2.50Buy → Hold
    Craig Hallum
    The Honest Company Inc.
    $HNST
    8/7/2025$7.00 → $6.00Market Perform
    Telsey Advisory Group
    The Honest Company Inc.
    $HNST
    1/10/2025$6.00 → $7.00Market Perform
    Telsey Advisory Group
    The Honest Company Inc.
    $HNST
    12/17/2024$7.00Buy → Hold
    Loop Capital
    More analyst ratings

    $BRSH
    $COOT
    $ELAB
    $FARM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Plunk Ken Allen was granted 515 shares (SEC Form 4)

    4 - WD 40 CO (0000105132) (Issuer)

    2/19/26 6:07:00 PM ET
    $WDFC
    Major Chemicals
    Industrials

    New insider Plunk Ken Allen claimed no ownership of stock in the company (SEC Form 3)

    3 - WD 40 CO (0000105132) (Issuer)

    2/19/26 6:05:43 PM ET
    $WDFC
    Major Chemicals
    Industrials

    EVP - CLO, CRCO Velasco Francisco sold $52,292 worth of shares (338 units at $154.71), decreasing direct ownership by 0.44% to 75,997 units (SEC Form 4)

    4 - PRICESMART INC (0001041803) (Issuer)

    2/18/26 3:58:12 PM ET
    $PSMT
    Department/Specialty Retail Stores
    Consumer Discretionary

    $BRSH
    $COOT
    $ELAB
    $FARM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Honest Company downgraded by Analyst

    Analyst downgraded Honest Company from Overweight to Underweight

    1/16/26 8:32:37 AM ET
    $HNST
    Catalog/Specialty Distribution
    Consumer Discretionary

    Canaccord Genuity initiated coverage on Veru with a new price target

    Canaccord Genuity initiated coverage of Veru with a rating of Buy and set a new price target of $25.00

    12/18/25 9:11:57 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Honest Company downgraded by Lake Street with a new price target

    Lake Street downgraded Honest Company from Buy to Hold and set a new price target of $3.00

    11/6/25 7:38:39 AM ET
    $HNST
    Catalog/Specialty Distribution
    Consumer Discretionary

    $BRSH
    $COOT
    $ELAB
    $FARM
    SEC Filings

    View All

    Farmer Brothers Company filed SEC Form 8-K: Leadership Update

    8-K - FARMER BROTHERS CO (0000034563) (Filer)

    2/20/26 4:15:43 PM ET
    $FARM
    Packaged Foods
    Consumer Staples

    WD-40 Company filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - WD 40 CO (0000105132) (Filer)

    2/19/26 4:08:56 PM ET
    $WDFC
    Major Chemicals
    Industrials

    Mangoceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - MANGOCEUTICALS, INC. (0001938046) (Filer)

    2/19/26 4:05:51 PM ET
    $MGRX
    Misc Health and Biotechnology Services
    Health Care

    $BRSH
    $COOT
    $ELAB
    $FARM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Pendarvis David bought $104,792 worth of shares (424 units at $247.15), increasing direct ownership by 7% to 6,898 units (SEC Form 4)

    4 - WD 40 CO (0000105132) (Issuer)

    2/6/26 6:11:21 PM ET
    $WDFC
    Major Chemicals
    Industrials

    Director Etchart Eric bought $97,010 worth of shares (500 units at $194.02), increasing direct ownership by 6% to 8,370 units (SEC Form 4)

    4 - WD 40 CO (0000105132) (Issuer)

    10/30/25 7:11:43 PM ET
    $WDFC
    Major Chemicals
    Industrials

    Director Pendarvis David bought $102,702 worth of shares (523 units at $196.37), increasing direct ownership by 10% to 5,862 units (SEC Form 4)

    4 - WD 40 CO (0000105132) (Issuer)

    10/30/25 4:55:42 PM ET
    $WDFC
    Major Chemicals
    Industrials

    $BRSH
    $COOT
    $ELAB
    $FARM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    WD-40 Company Announces Board Changes

    WD-40 Company (NASDAQ:WDFC), a global marketing organization dedicated to creating positive lasting memories by developing and selling products that solve problems in workshops, factories, and homes around the world, announced today the appointment of Ken Plunk to its board of directors, effective February 18, 2026. Mr. Plunk will serve as a member of the Audit and Finance Committees. Mr. Plunk is an experienced board member with deep expertise in finance, strategy, governance, and risk management. He is known for his ability to lead organizational transformations and execute strategic initiatives that improve financial performance and shareholder value across complex, global businesses.

    2/19/26 4:05:00 PM ET
    $WDFC
    Major Chemicals
    Industrials

    MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program

    Month over Month Growth of 336% and 54% Reduction in Customer Acquisition Cost (CAC) DALLAS, TX, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ:MGRX) (the "Company" or "MangoRx"), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine platform under the brands MangoRx and PeachesRx, today announced that MangoRx has experienced initial success for its newly launched all-inclusive injectable Testosterone Replacement Therapy (TRT) treatment program priced at $99 per month. The new TRT offer includes all doctor visits and medical consultations, lab work and analysis, and the medication to the extent prescribe

    2/19/26 4:05:00 PM ET
    $MGRX
    Misc Health and Biotechnology Services
    Health Care

    $30M Revenue Rocket, Super Spiders, and Biotech Patent Blitz Launch Morning Momentum

    DENVER, Feb. 19, 2026 (GLOBE NEWSWIRE) -- U.S. equity markets are pointing modestly lower this Thursday morning. The focus remains on earnings season kickoff and any fresh Fed commentary, but today's headlines are dominated by transformative deals and production milestones that are lifting small- and mid-cap names. Key Movers & Catalysts Driving the Tape Interactive Strength (NASDAQ:TRNR) is the standout gainer pre-market, surging more than 40% after announcing a definitive agreement to acquire Ergatta, the game-based connected fitness pioneer. The deal boosts TRNR's 2026 pro forma revenue guidance by 50%, to more than $30 million, with Ergatta alone expected to deliver > $10 million in

    2/19/26 11:00:26 AM ET
    $ELAB
    $TOVX
    $TRNR
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Consumer Electronics/Appliances
    Technology

    $BRSH
    $COOT
    $ELAB
    $FARM
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ENTADFI issued to VERU INC

    Submission status for VERU INC's drug ENTADFI (ORIG-1) with active ingredient FINASTERIDE;TADALAFIL has changed to 'Approval' on 12/09/2021. Application Category: NDA, Application Number: 215423, Application Classification: Type 4 - New Combination

    12/13/21 8:12:46 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BRSH
    $COOT
    $ELAB
    $FARM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Smart for Life Inc.

    SC 13G/A - SMART FOR LIFE, INC. (0001851860) (Subject)

    11/14/24 6:49:12 PM ET
    $SMFL
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SC 13G/A filed by The Honest Company Inc.

    SC 13G/A - Honest Company, Inc. (0001530979) (Subject)

    11/14/24 6:19:57 PM ET
    $HNST
    Catalog/Specialty Distribution
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by The Honest Company Inc.

    SC 13G/A - Honest Company, Inc. (0001530979) (Subject)

    11/14/24 5:53:21 PM ET
    $HNST
    Catalog/Specialty Distribution
    Consumer Discretionary

    $BRSH
    $COOT
    $ELAB
    $FARM
    Leadership Updates

    Live Leadership Updates

    View All

    WD-40 Company Announces Board Changes

    WD-40 Company (NASDAQ:WDFC), a global marketing organization dedicated to creating positive lasting memories by developing and selling products that solve problems in workshops, factories, and homes around the world, announced today the appointment of Ken Plunk to its board of directors, effective February 18, 2026. Mr. Plunk will serve as a member of the Audit and Finance Committees. Mr. Plunk is an experienced board member with deep expertise in finance, strategy, governance, and risk management. He is known for his ability to lead organizational transformations and execute strategic initiatives that improve financial performance and shareholder value across complex, global businesses.

    2/19/26 4:05:00 PM ET
    $WDFC
    Major Chemicals
    Industrials

    Reborn Coffee Announces the Formation of an Advisory Board and Appointment of Hisham Elkoustaf as Chair

    New Advisory Board to Drive Innovation and Growth Globally BREA, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Reborn Coffee Inc. (NASDAQ:REBN), a leader in the specialty coffee market, today announced the formation of its new advisory board to drive innovation and growth within the company and appointed Hisham Elkoustaf as its chair. The advisory boards will consist of a diverse group of professionals who will help to shape the strategic direction of Reborn Coffee and ensure that its remain committed to its values of sustainability and quality. Mr. Elkoustaf is an esteemed attorney with over 20 years of experience at the intersection of corporate law, economic development, and foreign poli

    10/23/25 9:00:01 AM ET
    $REBN
    Restaurants
    Consumer Discretionary

    PriceSmart Announces CFO Transition Plan

    Gualberto Hernandez to be appointed as CFO; Michael McCleary to Retire SAN DIEGO, May 9, 2025 /PRNewswire/ -- PriceSmart, Inc. ("PriceSmart" or the "Company") (NASDAQ:PSMT) today announced the appointment of Gualberto Hernandez as Executive Vice President and Chief Financial Officer effective June 1, 2025. PriceSmart's current Executive Vice President and Chief Financial Officer Michael McCleary resigned by mutual agreement with the Company, but will continue to serve as an Executive Vice President of the Company through September 30, 2025. Thereafter, Mr. McCleary has agreed to provide consulting support of up to 40 hours per month for three months following his resignation.

    5/9/25 4:05:00 PM ET
    $PSMT
    Department/Specialty Retail Stores
    Consumer Discretionary

    $BRSH
    $COOT
    $ELAB
    $FARM
    Financials

    Live finance-specific insights

    View All

    Farmer Brothers Coffee Reports Second Quarter Fiscal 2026 Financial Results

    FORT WORTH, Texas, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Farmer Brothers Coffee Co. (NASDAQ:FARM), a leading roaster, wholesaler and distributor of coffee, tea and allied products, announced today its second quarter fiscal 2026 financial results for the period ended Dec. 31, 2025. The company filed its Form 10-Q, which will be posted on the Investor Relations section of its website after the close of market Friday, Feb. 13. "As expected, the second quarter was a challenging one for Farmer Brothers. We, however, continued to see year-over-year improvement in selling and general and administrative cost and our gross margin remained above 35%, where we expect it to be for the remainder of fiscal

    2/13/26 4:15:00 PM ET
    $FARM
    Packaged Foods
    Consumer Staples

    The Honest Company to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

    LOS ANGELES, Feb. 11, 2026 (GLOBE NEWSWIRE) -- The Honest Company (NASDAQ:HNST), a personal care products company dedicated to creating products for everyone—from babies to adults—that raise the standards of clean and bring joy to every moment, today announced that it will report fourth quarter and full year 2025 financial results after the market closes on Wednesday, February 25, 2026. The Company will host a conference call and webcast to review these results at 1:45pm PT/4:45pm ET on the same day. For those interested in participating in the conference call by phone, please click here. Following registration, dial-in details will be provided via email. To avoid delays, we encourage par

    2/11/26 4:05:00 PM ET
    $HNST
    Catalog/Specialty Distribution
    Consumer Discretionary

    Veru Reports Fiscal 2026 First Quarter Financial Results and Clinical Program Progress

    -- Phase 2b PLATEAU clinical trial evaluating enobosarm in combination with semaglutide in older patients with obesity on track to initiate this quarter— --Company to host conference call and webcast today at 8:00 a.m. ET-- MIAMI, FL, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced financial results for its fiscal 2026 first quarter ended December 31, 2025, and provided a corporate update. "The strategy for the next generation of obesity drugs should be a combination therapy with GLP-1 receptor agonists for

    2/11/26 6:30:00 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care